New Japanese approvals include Zyprexa for bipolar depression
This article was originally published in Scrip
Executive Summary
The latest batch of additional indications to be formally approved in Japan includes Lilly's Zyprexa (olanzapine) for the improvement of depressive symptoms in bipolar disorder.